7108 Phase II study of IMC-1121B in patients with metastatic renal cell carcinoma (mRCC) following failure of VEGFR-2 tyrosine kinase inhibitor (TKI) therapy: interim results (IMCL CP12–0605/NCT00515697)
Year: 2009
Type: conference-abstract
Authors: J.A. Garcia, G. Hudes, T.K. Choueiri, W.M. Stadler, L. Wood, S. Bhatia, H. Youssoufian, E.K. Rowinsky, J.D. Schwartz, J.A. Thompson
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2007364258